12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
Clinical trial NCT03110575 · TERMINATED
Trial details
- NCT number
- NCT03110575
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-20
- Primary completion
- 2018-07-27
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.